Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validity of inpatient electronic health record-based measures of oxygen-related therapy in the United States: Lessons applicable for studying COVID-19 endpoints.
Fuller CC, Rosen E, Rai A, Cosgrove A, Miller K, Bright P, Haffenreffer K, Poland RE, Pratt N, Sands K, Shinde MU, Platt R, Cocoros NM, Klompas M, Dutcher SK. Fuller CC, et al. Among authors: bright p. Pharmacoepidemiol Drug Saf. 2024 Apr;33(4):e5785. doi: 10.1002/pds.5785. Pharmacoepidemiol Drug Saf. 2024. PMID: 38565526
Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021.
Fuller CC, Cosgrove A, Shinde M, Rosen E, Haffenreffer K, Hague C, McLean LE, Perlin J, Poland RE, Sands KE, Pratt N, Bright P, Platt R, Cocoros NM, Dutcher SK. Fuller CC, et al. Among authors: bright p. PLoS One. 2023 Jul 11;18(7):e0288284. doi: 10.1371/journal.pone.0288284. eCollection 2023. PLoS One. 2023. PMID: 37432951 Free PMC article.
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Hardt K, Vandebosch A, Sadoff J, Le Gars M, Truyers C, Lowson D, Van Dromme I, Vingerhoets J, Kamphuis T, Scheper G, Ruiz-Guiñazú J, Faust SN, Spinner CD, Schuitemaker H, Van Hoof J, Douoguih M, Struyf F; ENSEMBLE2 study group. Hardt K, et al. Lancet Infect Dis. 2022 Dec;22(12):1703-1715. doi: 10.1016/S1473-3099(22)00506-0. Epub 2022 Sep 13. Lancet Infect Dis. 2022. PMID: 36113538 Free PMC article. Clinical Trial.
154 results